Sangamo Therapeutics
SGMO
#7006
Rank
ยฃ0.32 B
Marketcap
ยฃ1.56
Share price
0.51%
Change (1 day)
429.01%
Change (1 year)

Revenue for Sangamo Therapeutics (SGMO)

Revenue in 2024 (TTM): ยฃ9.97 Million

According to Sangamo Therapeutics 's latest financial reports the company's current revenue (TTM ) is ยฃ9.77 Million. In 2023 the company made a revenue of ยฃ0.13 Billion an increase over the revenue in the year 2022 that were of ยฃ91.99 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Sangamo Therapeutics from 2000 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) ยฃ9.97 M-92.79%
2023 ยฃ0.13 B50.36%
2022 ยฃ91.99 M12.18%
2021 ยฃ82.01 M-5.42%
2020 ยฃ86.71 M11.01%
2019 ยฃ78.11 M17.41%
2018 ยฃ66.53 M145.9%
2017 ยฃ27.05 M72.19%
2016 ยฃ15.71 M-41.11%
2015 ยฃ26.68 M-9.44%
2014 ยฃ29.46 M101.38%
2013 ยฃ14.63 M9.2%
2012 ยฃ13.39 M101.81%
2011 ยฃ6.63 M-50.74%
2010 ยฃ13.47 M-1.7%
2009 ยฃ13.71 M24.15%
2008 ยฃ11.04 M141.15%
2007 ยฃ4.57 M13.77%
2006 ยฃ4.02 M179.57%
2005 ยฃ1.43 M110.21%
2004 ยฃ0.68 M-52.49%
2003 ยฃ1.44 M-46.77%
2002 ยฃ2.7 M-19.61%
2001 ยฃ3.36 M46.48%
2000 ยฃ2.3 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ยฃ22.13 B 226,364.12%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ1.66 B 16,962.76%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ25.89 B 264,899.59%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ7.69 B 78,681.46%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ34.37 B 351,614.59%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ69.81 B 714,211.31%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ2.19 B 22,322.49%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ49.73 B 508,810.97%๐Ÿ‡บ๐Ÿ‡ธ USA